
Ckim Pharma LLP
About Ckim Pharma LLP
Data last updated:
Ckim Pharma LLP is a limited liability partnership (LLP) based in Namchi, Sikkim, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAI-2659. Its GSTIN is 11AALFC9867E1ZB (Sikkim). The LLP holds 2 GST registrations, all of them active.
The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners including Shankar Agarwal and Hemant Amrish Parikh.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Namchi Bazar Namchi, Sikkim, India – 737126.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹14.59 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹31.74 Lakh (net margin -217.5%) and EBITDA of -₹11.66 Lakh (EBITDA margin -79.9%). Revenue has grown at a compounded annual rate (CAGR) of 277% over three years and 81% over five years.
Company details
Contact details
Ckim Pharma LLP's registered office is in Namchi, Sikkim. Its e-mail address is in the company report.
- Email
- Registered AddressNamchi Bazar Namchi, Sikkim, India – 737126
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ckim Pharma LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ckim Pharma LLP
FY 2025 filings availableCkim Pharma LLP reported revenue of ₹14.59 Lakh (up 32% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 81% over five years, including 32% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | -₹31.74 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -217.5% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Ckim Pharma LLP, buy the company report.
Designated partners of Ckim Pharma LLP
Ckim Pharma has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shankar Agarwal | Designated Partner | 13 Jan 2017 | 9 Years 10 Months | Current |
| Hemant Amrish Parikh Also directs: Viva Surbhi Biotech LLP, Vivanta Industries Limited, Vitale Beverages Private Limited and 5 more | Designated Partner | 14 Aug 2020 | 6 Years 3 Months | Current |
| Girish Bhatt Also directs: Vitale Beverages Private Limited, Viva Energy Fertilizers Private Limited, Vitaaglobal Bioscience Private Limited and 5 more | Designated Partner | 14 Aug 2020 | 6 Years 3 Months | Current |
| Mahabir Agarwal Prasad | Designated Partner | 13 Jan 2017 | 9 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Ckim Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ckim Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ckim Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 11AALFC9867E1ZB | Sikkim | Active | 01 Jul 2017 |
| 24AALFC9867E1Z4 | Gujarat | Active | 08 Jan 2021 |
To see the full GST registrations and return filing status of Ckim Pharma LLP, buy the company report.
Recent activity
Ckim Pharma LLP has 5 designated partner changes on record since 2017: 4 appointments and 1 cessation. The latest: Girish Bhatt was appointed as Designated Partner on 14 Aug 2020.
Frequently asked questions
Ckim Pharma is an active limited liability partnership based in Namchi, Sikkim, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2017 (9+ years old) and is registered under LLPIN AAI-2659.
Ckim Pharma has 4 current designated partners:
- Shankar Agarwal - Designated Partner
- Hemant Amrish Parikh - Designated Partner
- Girish Bhatt - Designated Partner
- Mahabir Agarwal Prasad - Designated Partner
The latest financial statements of Ckim Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ckim Pharma is 11AALFC9867E1ZB, registered in Sikkim. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AALFC9867E1Z4 (Gujarat).
The LLPIN (Limited Liability Partnership Identification Number) of Ckim Pharma is AAI-2659. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Ckim Pharma was incorporated on 13 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.
Girish Bhatt was appointed as Designated Partner on 14 Aug 2020. Hemant Amrish Parikh was appointed as Designated Partner on 14 Aug 2020. Harsh Kumar Doshi ceased to be Designated Partner on 11 Jul 2020. Ckim Pharma has 5 designated partner changes on record in total.
The registered office of Ckim Pharma is at Namchi Bazar Namchi, Sikkim, India – 737126.
Ckim Pharma operates in the pharma industry, in the drug formulation and development segment.
Ckim Pharma can be reached at its registered office: Namchi Bazar Namchi, Sikkim, India – 737126.

